Transcriptomics

Dataset Information

0

Construction of PYCARD-inducible system in two cancer cell lines, LNCaP (prostate cancer) and DLD1 (colorectal cancer)


ABSTRACT: Epigenetic gene silencing by aberrant DNA methylation is one of the important mechanisms leading to the loss of key cellular pathways in tumorigenesis. We previously reported that PYCARD (PYD and CARD domain containing), an apoptosis inducing gene, was frequently hypermethylated in prostate cancer in a tumor-specific manner (46/51: 90%), by methylation specific PCR (MSP). In order to examine the relationship between methylation status and level of the PYCARD protein expression in prostate cancer, we further performed immunohistochemical analyses of the 51 MSP-analyzed prostate cancer specimens and observed reduced or absent protein expression in tumors with aberrant methylation status of PYCARD. In contrast, PYCARD was unmethylated and expressed in normal prostatic tissues including epithelial, basal and inflammatory cells. Furthermore, we tried to identify downstream genes of PYCARD by microarray analyses using PYCARD inducible LNCaP prostate cancer cells. Interestingly, PYCARD induction upregulated PYDC1, another PYCARD homolog that associates with PYCARD and accelerates inflammation and apoptosis. Our present results suggest that aberrant methylation of PYCARD is an extremely frequent event and contributes to escape from apoptosis by reducing PYCARD expression in prostate cancer.

ORGANISM(S): Homo sapiens

PROVIDER: GSE142283 | GEO | 2020/12/19

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2012-12-06 | E-GEOD-35342 | biostudies-arrayexpress
2014-01-02 | E-GEOD-52687 | biostudies-arrayexpress
2019-06-30 | GSE107298 | GEO
2014-01-02 | E-GEOD-52567 | biostudies-arrayexpress
2014-01-02 | GSE52688 | GEO
2014-01-02 | GSE52687 | GEO
2014-07-08 | GSE54854 | GEO
2022-12-12 | GSE179214 | GEO
2012-12-06 | GSE35342 | GEO
2014-01-02 | GSE52567 | GEO